Table 2.
Patients and tissues characteristics.
| Groups | NL (n = 57) |
CLC (n = 314) |
MCRPC (n = 52) |
NEPC (n = 15) |
|---|---|---|---|---|
| Age (year), Median (Range) | 64 (48–80) | 63 (46–74) | 69 (48–91) | 77 (61–90) |
| PSA (ng/ml) | - | 9 (1.5–22) | 31.6 (3.2–2000) | 5.8 (0.03–12.8) |
| pTNM | NA | NA | NA | |
| pT2 | 204 | |||
| pT3 | 110 | |||
| ISUP Group | NA | NA | NA | |
| 1 | 77 | |||
| 2 | 89 | |||
| 3 | 128 | |||
| 4–5 | 20 |
NL: normal prostate tissue; CLC: hormone-naive clinically-localized cancer; MCRPC: metastatic castration resistant prostate cancer; y: years; NEPC: neuroendocrine prostate cancer; NA: not applicable.